BAH vs VRTX · P/E 10, rev $11.22B vs P/E 30, rev $3.33B
Booz Allen Hamilton Holding (BAH) versus Vertex Pharmaceuticals Inc (VRTX) — a side-by-side from cached financials, not a winner call.
Booz Allen Hamilton Holding (BAH) is a consulting services company listed on NYSE.
Vertex Pharmaceuticals Inc (VRTX) is a biotechnology company listed on US.
Latest reported BAH revenue for 2026-03-31 was $11.22B. Net income was $851.0M. Revenue was down 6.4% from 2025-03-31 to 2026-03-31. BAH currently screens at market cap $8.53B and trailing P/E 10.3.
Latest reported VRTX revenue for 2026-06-30 was $3.33B. Net income was $1.10B. Revenue was up 11.6% from 2026-03-31 to 2026-06-30. VRTX currently screens at market cap $106.87B and trailing P/E 29.7.
BAH currently screens at market cap $8.53B and trailing P/E 10.3. VRTX currently screens at market cap $106.87B and trailing P/E 29.7.
Not investment advice. Open the BAH and VRTX stock pages for the full models.
Not investment advice.